Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-Alfatide Ⅱ PET/CT in the Diagnosis and Treatment Response Evaluation of Breast Cancer Patients

NCT02582801 is registered in ClinicalTrials.gov with Jiang Wu as lead sponsor.

NCT NCT02582801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02582801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-Alfatide Ⅱ PET/CT in the Diagnosis and Treatment Response Evaluation of Breast Cancer Patients
Lead sponsor
Jiang Wu
Phase
Phase 1
Overall status
Terminated
Start date
October 31, 2015
Completion date
September 30, 2019
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer